COPPA, Anna
 Distribuzione geografica
Continente #
NA - Nord America 3.227
EU - Europa 1.539
AS - Asia 643
SA - Sud America 57
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.492
Nazione #
US - Stati Uniti d'America 3.195
IT - Italia 545
SG - Singapore 279
UA - Ucraina 276
IN - India 198
SE - Svezia 188
FI - Finlandia 131
DE - Germania 123
CN - Cina 117
RU - Federazione Russa 90
GB - Regno Unito 62
BR - Brasile 32
CA - Canada 28
ID - Indonesia 21
TG - Togo 19
BG - Bulgaria 18
IE - Irlanda 18
AR - Argentina 16
BE - Belgio 15
FR - Francia 12
NL - Olanda 12
RO - Romania 9
LT - Lituania 8
CH - Svizzera 7
AT - Austria 6
NO - Norvegia 6
IR - Iran 5
TR - Turchia 5
HK - Hong Kong 4
EC - Ecuador 3
ES - Italia 3
MX - Messico 3
CO - Colombia 2
DK - Danimarca 2
EE - Estonia 2
IQ - Iraq 2
JO - Giordania 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PL - Polonia 2
ZA - Sudafrica 2
AM - Armenia 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 5.492
Città #
Fairfield 393
Chandler 322
Rome 228
Woodbridge 221
Ashburn 173
Houston 163
Singapore 160
Seattle 137
Ann Arbor 136
Cambridge 124
Wilmington 123
Jacksonville 113
Princeton 101
Plano 86
Beijing 65
Santa Clara 64
New York 52
Lawrence 50
San Paolo di Civitate 45
Dearborn 43
Boardman 41
Helsinki 40
Boston 38
Milan 37
Millbury 37
Falkenstein 29
Andover 27
Moscow 25
San Diego 24
Jakarta 21
Los Angeles 21
Des Moines 19
Lomé 19
Dublin 18
Sofia 18
Grafing 17
Toronto 17
Federal 16
Fremont 16
Norwalk 16
Lappeenranta 14
Dallas 13
Bremen 12
Brussels 11
Bühl 11
London 11
Auburn Hills 10
Council Bluffs 9
San Benedetto del Tronto 8
Chennai 7
Phoenix 7
San Mateo 7
Oslo 6
Philadelphia 6
Redmond 6
Yubileyny 6
Arezzo 5
Benevento 5
Laurel 5
Nuremberg 5
Bern 4
Bethesda 4
Centrale 4
Frankfurt am Main 4
Guangzhou 4
Hong Kong 4
Indiana 4
Montesilvano Marina 4
Nanjing 4
Naples 4
Perugia 4
Redwood City 4
São Paulo 4
Verona 4
Waanrode 4
Buffalo 3
Cardiff 3
Falls Church 3
Florence 3
Izmir 3
Kunming 3
Leawood 3
Leicester 3
Mannheim 3
Monte Compatri 3
Montreal 3
Ottawa 3
Pisa 3
Provo 3
Sacramento 3
Sassuolo 3
Southend 3
Stuttgart 3
Troina 3
Washington 3
Americana 2
Amman 2
Anzio 2
Ascoli Piceno 2
Batangas 2
Totale 3.589
Nome #
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 153
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 132
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors 128
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer. 126
PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma 125
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 116
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 104
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer 99
Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14. 99
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 97
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer 94
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology 93
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families 92
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 90
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 90
A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma 88
A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours 88
The role of peroxiredoxins in cancer 86
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 84
A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression 83
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report 82
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 78
Overexpression of TGFb type II receptor in human neuroblastoma cells reduces cell growth and induces neuronal phenotype 77
Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes 76
Nuclear fluorescence serum reactivity on monkey oesophagus: a new antibody for the follow-up of coeliac disease? 74
The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration 71
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk 70
HE4 in the differential diagnosis of a pelvic mass: A case report 69
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study 68
EGF and TGF-β1 effects on thyroid function 68
Analysis of TGFb receptors expression in normal and TGFb resistant rat thyroid cells 66
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases 66
Epithelial rat thyroid cell clones, excaping from TGFbeta negative control, are still inhibited by this factor in the ability to trap iodide 65
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 64
SMAD NUCLEOCYTOPLASMIC SHUTTLING IN THE THYROID TUMORIGENESIS. 61
Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores 61
Role of reduced expression of SMAD4 in papillary thyroid carcinoma 59
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms 57
NSD1 mutations and pediatric high-grade gliomas: a comparative genomic study in primary and recurrent tumors 56
The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals 56
Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. 55
CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma 55
Effects of the Smad4 C324Y mutation on thyroid cell proliferation 54
Role of Smads in the tumorigenicity and metastatic potential of K-ras transformed thyroid cells. 53
A novel BRCA2 splice variant identified in a young woman 53
Loss of TGFb mediated growth regulation in transformed thyroid cells is associated with alterations in the expression of TGFb receptors. 50
Effetti sulla proliferazione e sulle funzioni di cellule di tiroide normali e TGFb resistenti 50
TGFb1 enhances the invasiveness of human MDA-MB-231 breast cancer cells up-regulating urokinase activity 50
ENIGMA CHEK2gether Project. A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk 49
Smad4 control of rat thyroid follicular cells differentiation 49
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 48
Okadaic acid influences thyroid cell proliferation 47
Increased expression of cyclin D1 is associated with reduced levels of type II TGFb receptor (TbRII) in malignant thyroid cells 47
TGFbeta regulates differentiation and proliferation of human neuroblastoma 47
Increased expression of cyclin D1 is associated with impairment of TGFb-growth inhibitory signal at the level of either type II receptor (TbRII) or Smad proteins in Ras-transformed rat thyroid cells and in human thyroid tumours.. 46
Oncogenes and antioncogenes involved in human thyroid carcinogenesis 46
Analysis of expression of TGFb growth factor receptors in benign and malignant thyroid tumors 45
Reduction of TGFb receptor type II correlates with resistence in TGFb growth inibition in rat thyroid cells. 44
Serum gastrin, fasting and afterstimulation, in systemic sclerosis 44
Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastatic potential of K-ras-transformed thyroid cells. 44
Loss of TGFb mediated growth regulation in K-Ras transformed thyroid cells is asssociated with reduced expression of Type II TGFb Receptor. 42
TGFb activates divergent postreceptorial pathways in epithelial rat thyroid cells in culture 42
Il recettore di tipo II del TGFb si comporta come un antioncogene quando é overespresso in cellule di tiroide trasformate 41
Expression of diamine oxidase (DAO), sucrose and CEA in human colon CaCO-2 cell line 41
Molecular mechanism of thyroid neoplastic transformation 40
TGF-b1 signalling in K-ras transformed thyroid cells 40
SMAD-4 altered nucleo-cytoplasmic shuttling in thyroid tumours: a new intriguing link in cancer development 39
Increased type II TGFbeta receptor expression in liver cells during cholesterol challenge 39
Evaluation using radioisotopes (I125) of the artightness of root canal obturation obtained with lateral and vertical condensation technics 39
Increased TGFb type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. 39
Increased TbRII expression reduces tumorigenicity and induces neuronal differentiation of human neuroblastoma cells 38
Monitoring of serum alpha-fetoprotein levels in children with chronic hepatitis B virus infection 38
Alterations of TGFb pathway in neoplastic thyroid cells 37
Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway 37
Markers neoplastici e sierici nelle poliposi del colon-retto 36
Transforming growth factor beta-1 treatment of human MDA-MB-231 breast cancer cells stimulates plasmin dependent MMP-9 and membrane dependent MMP-2 activation 35
Regulation of MHC Class I gene expression: role of TGFb1 35
Smad4 altered expression is a new important step of TGF-BETA signal impairment in thyroid tumorigenesis 35
Restored expression of TGFb type II receptor in k-ras transformed thyroid cells, TGFb resistant, reverts their malignant phenotype 35
Special volunteer 34
THE PHOSPHATASE INHIBITOR OKADAIC ACID STIMULATED THE TSH-INDUCED G1-S PHASE TRANSITION IN THYROID CELLS 34
Carcinoma del colon: correlazione tra l'espressione del recettore per l'EGF e markers tumorali tissutali 34
Erb-B2 overexpression alters the rat cells response to growth factors. 32
Association of screening for congenital adrenal hyperplasia with that of congenital hypotiroidism: microfilter paper method for 17- hydroxyprogesterone radioimmunoassay 32
TGFbeta downregulation of MCH class I in thyreocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors 31
TGFb type II recepor acts as antioncogene when overexpressed in human neuroblastoma cells. 30
Visiting fellow 30
Overexpression of TGFb receptor type II (TbRII) reduces malignant phenotype of K-Ras-transformed thyroid cells 30
Correlazione tra l'espressione del recettore per l'EGF ed alcuni markers tumorali tissutali in tiroidi umane con patologia benigna e maligna 29
Livelli sierici di Tissue Polypeptide Antigen (TPA) in soggetti affetti da malattie ematiche 27
TGFb effects on expression of cyclins and cyclin-dependent kinases in rat thyroid cells 26
Epidermal growth factor receptor and tissue tumor markers in human intracranial neoplasms 26
TGF-beta control of rat thyroid follicular cells differentiation 25
L'endemia gozzigena in Campania: indagine nella provincia di Caserta 24
Role of Smad4 in the regulation of thyroid differentiation genes. 22
Thyroid function and etiological factors in same areas of endemic goitier in south of Italy 18
Thyroid tumors display reduced levels of TGFb receptor type II m-RNA and protein 17
Recenti acquisizioni sugli indicatori biochimici presenti nel siero, nel liquido di lavaggio bronchiale e nel tessuto polmonare di soggetti affetti da patologia neoplastica 15
Visiting Researcher presso il Laboratorio di DNA Repair 15
Expression of diamine oxidase, sucrose and CEA in differentiating colon cancer cells. 14
Totale 5.660
Categoria #
all - tutte 18.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020311 0 0 0 0 0 0 0 0 83 122 66 40
2020/2021481 52 68 11 27 10 69 6 37 35 128 35 3
2021/2022947 14 66 72 52 121 22 22 88 64 79 171 176
2022/20231.085 208 212 82 106 118 114 36 54 86 16 36 17
2023/2024649 46 59 39 34 67 97 47 40 4 81 59 76
2024/2025701 54 31 100 93 76 123 98 104 22 0 0 0
Totale 5.672